$5.19 Billion is the total value of OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s 296 reported holdings in Q1 2018. The portfolio turnover from Q4 2017 to Q1 2018 was 10.0% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IGI LABOnote3 | $6,965,000,000 | +5.9% | 7,500,000 | 0.0% | 0.13% | +14.5% | ||
ADS | ALLIANCE | $2,129,000,000 | -16.0% | 10,000 | 0.0% | 0.04% | -8.9% | |
THC | TENET HE | $1,212,000,000 | +59.9% | 50,000 | 0.0% | 0.02% | +76.9% | |
HYG | ISHARESput | $1,110,000,000 | +41.4% | 1,500,000 | 0.0% | 0.02% | +50.0% | |
INFINERAdbcv1 | $1,000,000,000 | +0.9% | 1,000,000 | 0.0% | 0.02% | +5.6% | ||
ELECTRONnote0 | $973,000,000 | +0.6% | 1,000,000 | 0.0% | 0.02% | +11.8% | ||
TWITTERnote0 | $958,000,000 | 0.0% | 1,000,000 | 0.0% | 0.02% | +5.9% | ||
NUANCE Cdbcv1 | $955,000,000 | -0.4% | 1,000,000 | 0.0% | 0.02% | +5.9% | ||
FINISARnote0 | $901,000,000 | -3.3% | 1,000,000 | 0.0% | 0.02% | 0.0% | ||
ENSCO JEnote3 | $804,000,000 | -9.9% | 1,000,000 | 0.0% | 0.02% | -6.2% | ||
OREXQ | OREXIGEN | $0 | – | 33,333 | 0.0% | 0.00% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
META PLATF | 36 | Q3 2023 | 2.3% |
SPDR S&P 5 | 33 | Q3 2023 | 0.7% |
ACTIVISION | 29 | Q3 2023 | 71.3% |
AMAZON COM | 29 | Q3 2023 | 0.8% |
GAMING & L | 29 | Q3 2023 | 0.8% |
SPDR S&P | 29 | Q1 2023 | 0.1% |
DISNEY W | 28 | Q3 2021 | 2.0% |
POST HLD | 27 | Q2 2020 | 1.8% |
GENERAL | 27 | Q3 2022 | 1.4% |
CAMDEN PPT | 27 | Q3 2023 | 0.6% |
View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
HERON THERAPEUTICS, INC. /DE/Sold out | February 13, 2023 | 0 | 0.0% |
MAGELLAN HEALTH INCSold out | February 13, 2023 | 0 | 0.0% |
New Providence Acquisition Corp. II | February 13, 2023 | 2,227,500 | 8.9% |
Nuance Communications, Inc.Sold out | February 13, 2023 | 0 | 0.0% |
SCP & CO Healthcare Acquisition CoSold out | February 13, 2023 | 0 | 0.0% |
ACORDA THERAPEUTICS INCSold out | February 14, 2022 | 0 | 0.0% |
Amryt Pharma plc | February 14, 2022 | 9,950,000 | 3.1% |
Evolv Technologies Holdings, Inc. | February 14, 2022 | 1,547,311 | 1.1% |
GreenSky, Inc. | February 14, 2022 | 698,553 | 0.8% |
GTY Technology Holdings Inc. | February 14, 2022 | 758,000 | 1.3% |
View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR/A | 2024-05-15 |
13F-HR/A | 2024-05-15 |
13F-HR/A | 2024-05-15 |
13F-HR/A | 2024-05-15 |
13F-HR | 2024-05-15 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR/A | 2024-02-14 |
13F-HR | 2024-02-14 |
View OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC)'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.